Search Results

There are 13061 results for: content related to: Randomized phase II trial of two different schedules of docetaxel plus cisplatin as first-line therapy in advanced nonsmall cell lung cancer

  1. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  2. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  3. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  4. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  5. You have free access to this content
    Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326)


    Volume 104, Issue 12, 15 December 2005, Pages: 2766–2774, Chandra P. Belani and Frank Fossella

    Version of Record online : 15 NOV 2005, DOI: 10.1002/cncr.21495

  6. You have full text access to this OnlineOpen article
    Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study

    Thoracic Cancer

    Volume 7, Issue 2, March 2016, Pages: 207–214, Sun Min Lim, Byeong Bae Park, Keun-Chil Park, Hoon-Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung-Sei Lee, Jin-Hyoung Kang, Se-Hoon Park, Gyeong-Won Lee, Hyo-Rac Lee, Jae Hong Seo, Yong Tae Kim, Sung Hyun Yang and Joo-Hang Kim

    Version of Record online : 1 NOV 2015, DOI: 10.1111/1759-7714.12315

  7. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  8. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  9. Docetaxel Nanotechnology in Anticancer Therapy


    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  10. From Mouse to Man: Predictions of Human Pharmacokinetics of Orally Administered Docetaxel From Preclinical Studies

    The Journal of Clinical Pharmacology

    Volume 52, Issue 3, March 2012, Pages: 370–380, Mr S. L. W. Koolen, Dr R. A. B. van Waterschoot, Dr O. van Tellingen, Dr A. H. Schinkel, Dr J. H. Beijnen, Dr J. H. M. Schellens and Dr A. D. R. Huitema

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010397051

  11. You have full text access to this OnlineOpen article
    Phase I/II trial of 2-weekly docetaxel combined with cisplatin plus fluorouracil in metastatic esophageal cancer (JCOG0807)

    Cancer Science

    Volume 105, Issue 9, September 2014, Pages: 1189–1195, Shuichi Hironaka, Yasuhiro Tsubosa, Junki Mizusawa, Takayuki Kii, Ken Kato, Takahiro Tsushima, Keisho Chin, Akihisa Tomori, Tatsuya Okuno, Toshikatsu Taniki, Takashi Ura, Hisayuki Matsushita, Takashi Kojima, Yuichiro Doki, Hitoshi Kusaba, Kazumasa Fujitani, Koichi Taira, Shiko Seki, Tsutomu Nakamura, Yuko Kitagawa and Japan Esophageal Oncology Group/Japan Clinical Oncology Group

    Version of Record online : 23 SEP 2014, DOI: 10.1111/cas.12486

  12. Chemotherapy for hormone-refractory prostate cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Craig Harrison, Bernadette Coles, John Stafforth, Timothy Wilt and Malcolm Mason

    Published Online : 18 OCT 2006, DOI: 10.1002/14651858.CD005247.pub2

  13. You have free access to this content
    The effect of Echinacea purpurea on the pharmacokinetics of docetaxel

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 467–474, Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Jacobus A. Burgers, Marja Mergui-Roelvink, Marianne Keessen, Serena Marchetti, Jos H. Beijnen and Jan H. M. Schellens

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12159

  14. You have free access to this content
    Current and emerging treatment modalities for metastatic castration-resistant prostate cancer

    BJU International

    Volume 107, Issue s2, April 2011, Pages: 13–20, Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg and Stéphane Oudard

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10036.x

  15. You have free access to this content
    A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer


    Volume 118, Issue 13, 1 July 2012, Pages: 3283–3293, Angeles Alvarez Secord, Andrew Berchuck, Robert V. Higgins, Lawrence R. Nycum, Matthew F. Kohler, Larry E. Puls, Robert W. Holloway, George S. Lewandowski, Fidel A. Valea and Laura J. Havrilesky

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26610

  16. You have free access to this content
    A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy


    Volume 117, Issue 10, 15 May 2011, Pages: 2050–2057, Hei-Cheul Jeung, Sun Young Rha, Chong Kun Im, Sang Joon Shin, Joong Bae Ahn, Woo Ick Yang, Jae Kyung Roh, Sung Hoon Noh and Hyun Cheol Chung

    Version of Record online : 29 NOV 2010, DOI: 10.1002/cncr.25729

  17. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  18. Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study

    Diseases of the Esophagus

    Volume 27, Issue 8, November/December 2014, Pages: 737–743, T. Moriwaki, T. Kajiwara, T. Matsumoto, H. Suzuki, Y. Hiroshima, K. Matsuda, S. Hirai, Y. Yamamoto, T. Yamada, A. Sugaya, M. Kobayashi, S. Endo, K. Ishige, T. Nishina and I. Hyodo

    Version of Record online : 11 JUN 2014, DOI: 10.1111/dote.12246

  19. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  20. Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model

    International Journal of Cancer

    Volume 138, Issue 3, 1 February 2016, Pages: 758–769, Jeroen J.M.A. Hendrikx, Jurjen S. Lagas, Ji-Ying Song, Hilde Rosing, Jan H.M. Schellens, Jos H. Beijnen, Sven Rottenberg and Alfred H. Schinkel

    Version of Record online : 21 SEP 2015, DOI: 10.1002/ijc.29812